Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung
- PMID: 17290396
- DOI: 10.1002/ijc.22585
Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung
Abstract
Previously, we reported gene amplification at chromosome 3q26-27 in more than one third of squamous cell carcinomas of the lung. Frequent amplification of eukaryotic translation initiation factor 4G on 3q27.1 indicated a possible role of this amplification in translation initiation. The analysis of 61 squamous cell lung carcinomas shows that the percentage of carcinomas with a 3q27.1 amplification increases in higher malignant tumors. Non-invasive (T1) and minimal-invasive (T2) tumor stages showed similar percentages of amplified and non-amplified tumors, whereas locally-invasive (T3) tumors revealed a statistically significant (p < 0.05) increased percentage of amplified tumors. Microarrays were used to analyze the expression pattern of genes mapping in the amplified domain and its flanking regions (3q25-28) as well as the expression of genes directly or indirectly associated with translation initiation in squamous cell carcinoma, large cell carcinoma, adenocarcinoma and small cell carcinoma. Three genes, namely FXR1, CLAPM1 and EIF4G, are most frequently overexpressed in the center of the amplified domain in squamous cell carcinomas. The eukaryotic translation initiation factors 4A1, 2B and 4B as well as the poly(A)-binding protein PABPC1 where found to be overexpressed in all lung cancer entities. We found, however, no overexpression of eIF4E. Our results contribute to the understanding of the frequent amplification processes in squamous cell carcinomas of the lung and to the understanding of the translation initiation that appears not to require eIF4E in lung carcinogenesis.
Similar articles
-
Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.Cancer Res. 1997 Jun 1;57(11):2290-4. Cancer Res. 1997. PMID: 9187134
-
3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.Clin Cancer Res. 2007 Apr 1;13(7):1995-2004. doi: 10.1158/1078-0432.CCR-06-2483. Clin Cancer Res. 2007. PMID: 17404079
-
[Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):324-7. Zhonghua Bing Li Xue Za Zhi. 2004. PMID: 15363316 Chinese.
-
[Translational research and diagnostics in lung cancer].Pathologe. 2012 Nov;33 Suppl 2:269-72. doi: 10.1007/s00292-012-1664-y. Pathologe. 2012. PMID: 22968733 Review. German.
-
Molecular classification and molecular genetics of human lung cancers.Semin Oncol. 2004 Feb;31(1 Suppl 1):4-19. doi: 10.1053/j.seminoncol.2003.12.009. Semin Oncol. 2004. PMID: 14981576 Review.
Cited by
-
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3469-74. doi: 10.1073/pnas.1421975112. Epub 2015 Mar 2. Proc Natl Acad Sci U S A. 2015. PMID: 25733852 Free PMC article.
-
RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.World J Surg Oncol. 2012 Jun 26;10:119. doi: 10.1186/1477-7819-10-119. World J Surg Oncol. 2012. PMID: 22734884 Free PMC article.
-
Comprehensive bioinformatics analysis of FXR1 across pan-cancer: Unraveling its diagnostic, prognostic, and immunological significance.Medicine (Baltimore). 2023 Dec 1;102(48):e36456. doi: 10.1097/MD.0000000000036456. Medicine (Baltimore). 2023. PMID: 38050239 Free PMC article.
-
Screening and Identification of Key Biomarkers in Metastatic Uveal Melanoma: Evidence from a Bioinformatic Analysis.J Clin Med. 2022 Dec 5;11(23):7224. doi: 10.3390/jcm11237224. J Clin Med. 2022. PMID: 36498797 Free PMC article.
-
Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.Mol Cancer. 2010 Apr 16;9:78. doi: 10.1186/1476-4598-9-78. Mol Cancer. 2010. PMID: 20398343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
